| Year |
Citation |
Score |
| 2025 |
Lanning NJ, Mancour L, Argetsinger LS, Archer S, Carter-Su C. Identification of βIIΣ1-spectrin as a binding partner of the GH-regulated human obesity scaffold protein SH2B1. Endocrinology. PMID 39801013 DOI: 10.1210/endocr/bqaf003 |
0.609 |
|
| 2020 |
Salladay-Perez IA, Lanning NJ. Assessing the Global Impact of an Adenylate Kinase Isoenzyme on AMPK and mTOR Signaling Pathways Through Metabolic Profiling in both Brain and Lung Cancer Cell Lines The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04621 |
0.38 |
|
| 2019 |
Castellanos E, Lanning NJ. Phosphorylation of OXPHOS Machinery Subunits: Functional Implications in Cell Biology and Disease. The Yale Journal of Biology and Medicine. 92: 523-531. PMID 31543713 |
0.342 |
|
| 2018 |
Lanning NJ, VanOpstall C, Goodall ML, MacKeigan JP, Looyenga BD. LRRK2 Deficiency Impairs trans-Golgi to Lysosome Trafficking and Endocytic Cargo Degradation in Human Renal Proximal Tubule Epithelial Cells. American Journal of Physiology. Renal Physiology. PMID 30089035 DOI: 10.1152/Ajprenal.00009.2018 |
0.373 |
|
| 2017 |
Lanning NJ, Castle JP, Singh SJ, Leon AN, Tovar EA, Sanghera A, MacKeigan JP, Filipp FV, Graveel CR. Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities. Cancer & Metabolism. 5: 6. PMID 28852500 DOI: 10.1186/S40170-017-0168-X |
0.331 |
|
| 2017 |
Sasi NK, Bhutkar A, Lanning NJ, MacKeigan JP, Weinreich M. DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways. Neoplasia (New York, N.Y.). 19: 439-450. PMID 28448802 DOI: 10.1016/J.Neo.2017.03.001 |
0.422 |
|
| 2014 |
Lanning NJ, Looyenga BD, Kauffman AL, Niemi NM, Sudderth J, DeBerardinis RJ, MacKeigan JP. A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels. Cell Reports. 7: 907-17. PMID 24767988 DOI: 10.1016/J.Celrep.2014.03.065 |
0.369 |
|
| 2014 |
Niemi NM, Sacoman JL, Westrate LM, Gaither LA, Lanning NJ, Martin KR, MacKeigan JP. The pseudophosphatase MK-STYX physically and genetically interacts with the mitochondrial phosphatase PTPMT1. Plos One. 9: e93896. PMID 24709986 DOI: 10.1371/Journal.Pone.0093896 |
0.434 |
|
| 2014 |
Lanning NJ, Jose P, Monks NR, Davidson PJ, Borgman AS, Chang T, Peck AS, Monsma DJ, Peterson CA, Jeff MP, Nickoloff BJ. Abstract A37: Complex crosstalk between MAPK signaling and energy metabolism in melanoma Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-A37 |
0.359 |
|
| 2013 |
Su HW, Lanning NJ, Morris DL, Argetsinger LS, Lumeng CN, Carter-Su C. Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility. Journal of Cell Science. 126: 1733-43. PMID 23444381 DOI: 10.1242/Jcs.113050 |
0.607 |
|
| 2013 |
Niemi NM, Lanning NJ, Westrate LM, MacKeigan JP. Downregulation of the mitochondrial phosphatase PTPMT1 is sufficient to promote cancer cell death. Plos One. 8: e53803. PMID 23326511 DOI: 10.1371/Journal.Pone.0053803 |
0.347 |
|
| 2011 |
Lanning NJ, Su HW, Argetsinger LS, Carter-Su C. Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number. Journal of Cell Science. 124: 3095-105. PMID 21878491 DOI: 10.1242/Jcs.081547 |
0.613 |
|
| 2011 |
Fogg VC, Lanning NJ, Mackeigan JP. Mitochondria in cancer: at the crossroads of life and death. Chinese Journal of Cancer. 30: 526-39. PMID 21801601 DOI: 10.5732/Cjc.011.10018 |
0.312 |
|
| 2011 |
Cui TX, Lin G, LaPensee CR, Calinescu AA, Rathore M, Streeter C, Piwien-Pilipuk G, Lanning N, Jin H, Carter-Su C, Qin ZS, Schwartz J. C/EBPβ mediates growth hormone-regulated expression of multiple target genes. Molecular Endocrinology (Baltimore, Md.). 25: 681-93. PMID 21292824 DOI: 10.1210/Me.2010-0232 |
0.581 |
|
| 2011 |
Niemi NM, Lanning NJ, Klomp JA, Tait SW, Xu Y, Dykema KJ, Murphy LO, Gaither LA, Xu HE, Furge KA, Green DR, MacKeigan JP. MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis. Molecular and Cellular Biology. 31: 1357-68. PMID 21262771 DOI: 10.1128/Mcb.00788-10 |
0.444 |
|
| 2008 |
Jin H, Lanning NJ, Carter-Su C. JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells. Molecular Endocrinology (Baltimore, Md.). 22: 1825-41. PMID 18499741 DOI: 10.1210/Me.2008-0015 |
0.615 |
|
| 2006 |
Lanning NJ, Carter-Su C. Recent advances in growth hormone signaling. Reviews in Endocrine & Metabolic Disorders. 7: 225-35. PMID 17308965 DOI: 10.1007/S11154-007-9025-5 |
0.607 |
|
| 2005 |
Zhang YW, Su Y, Lanning N, Gustafson M, Shinomiya N, Zhao P, Cao B, Tsarfaty G, Wang LM, Hay R, Vande Woude GF. Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor. Oncogene. 24: 101-6. PMID 15531925 DOI: 10.1038/Sj.Onc.1208181 |
0.333 |
|
| Show low-probability matches. |